[go: up one dir, main page]

CN114014896B - Separation and purification method of high-purity 3' -sialyllactose - Google Patents

Separation and purification method of high-purity 3' -sialyllactose Download PDF

Info

Publication number
CN114014896B
CN114014896B CN202111179169.4A CN202111179169A CN114014896B CN 114014896 B CN114014896 B CN 114014896B CN 202111179169 A CN202111179169 A CN 202111179169A CN 114014896 B CN114014896 B CN 114014896B
Authority
CN
China
Prior art keywords
purity
membrane
filtrate
sialyllactose
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111179169.4A
Other languages
Chinese (zh)
Other versions
CN114014896A (en
Inventor
袁丽霞
陈祥松
吴金勇
李翔宇
李忠奎
孙立洁
姚建铭
王力
王刚
郑家妹
费贤春
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hefei Institutes of Physical Science of CAS
Cabio Biotech Wuhan Co Ltd
Original Assignee
Hefei Institutes of Physical Science of CAS
Cabio Biotech Wuhan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hefei Institutes of Physical Science of CAS, Cabio Biotech Wuhan Co Ltd filed Critical Hefei Institutes of Physical Science of CAS
Priority to CN202111179169.4A priority Critical patent/CN114014896B/en
Publication of CN114014896A publication Critical patent/CN114014896A/en
Application granted granted Critical
Publication of CN114014896B publication Critical patent/CN114014896B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)

Abstract

本发明属于唾液酸乳糖分离纯化领域,具体涉及一种高纯度3’‑唾液酸乳糖的分离纯化方法,包括对转化液进行加热灭酶过滤、调节滤液pH至碱性后过滤,将滤液的pH调节至中性、经浓缩、离子吸附、干燥等步骤,得到分离纯化的3’‑SL;本发明采用加热灭酶和调节pH至碱性两种方式综合提升转化液中蛋白等大分子物质的去除率,同时控制浓缩液中3’‑SL的浓度,对于阴阳离子吸附纯化进一步提高产物3’‑SL的纯度具有重要作用,综合上述方法获得的产物3’‑SL的纯度≥96%。

The invention belongs to the field of separation and purification of sialyllactose, and specifically relates to a method for separation and purification of high-purity 3'-sialyllactose, which includes heating and enzymatic filtration of the transformation liquid, adjusting the pH of the filtrate to alkaline and then filtering, and adjusting the pH of the filtrate to Adjust to neutrality, and undergo steps such as concentration, ion adsorption, and drying to obtain separated and purified 3'-SL; the present invention uses two methods: heating to inactivate enzymes and adjusting pH to alkaline to comprehensively improve the concentration of proteins and other macromolecular substances in the conversion solution. The removal rate, while controlling the concentration of 3'-SL in the concentrated solution, plays an important role in further improving the purity of the product 3'-SL for anion and cation adsorption purification. The purity of the product 3'-SL obtained by combining the above methods is ≥96%.

Description

一种高纯度3`-唾液酸乳糖的分离纯化方法A method for separating and purifying high-purity 3`-sialyllactose

技术领域Technical field

本发明属于唾液酸乳糖分离纯化领域,具体涉及一种高纯度3’-唾液酸乳糖的分离纯化方法。The invention belongs to the field of separation and purification of sialyllactose, and specifically relates to a method for separation and purification of high-purity 3'-sialyllactose.

背景技术Background technique

人乳低聚糖(HMOS)是继乳糖和脂肪之后,人乳中含量第三丰富的成分,具有重要的生物学功能。唾液酸寡糖(SL)是一种酸性的人乳低聚糖,根据唾液酸与乳糖部分结合的位置可分为3’-唾液酸乳糖(3’-SL)和6’-唾液酸乳糖 (6’-SL),现有研究表明3’-SL对婴儿具有重要作用,包括中和肠道细菌产生的毒素、防止细菌或病毒粘附到肠道上皮表面等方面。尽管3’-SL具有重要的生物学功能,但目前仍缺乏经济高效的工业化生产方法,因此,开发低成本底物生产及纯化3’-SL的方法,对于3’-SL的推广应用具有重要意义。Human milk oligosaccharides (HMOS) are the third most abundant component in human milk after lactose and fat and have important biological functions. Sialyl oligosaccharide (SL) is an acidic human milk oligosaccharide. It can be divided into 3'-sialyllactose (3'-SL) and 6'-sialyllactose (SL) according to the binding position of sialic acid and lactose moiety. 6'-SL), existing research shows that 3'-SL plays an important role in infants, including neutralizing toxins produced by intestinal bacteria and preventing bacteria or viruses from adhering to the intestinal epithelial surface. Although 3'-SL has important biological functions, there is still a lack of cost-effective industrial production methods. Therefore, the development of low-cost substrate production and purification methods for 3'-SL is important for the promotion and application of 3'-SL. significance.

现有制备唾液酸乳糖的方法如申请号为CN201910787973.7,专利名称为一种制备唾液酸乳糖的方法,该发明采用单菌多酶法结合一步纯化及固定化方法将多酶进行固定,实现一锅法唾液酸乳糖制备过程中CTP再生和多酶的循环利用,该方法具有产量高、成本低、周期短等优势,但该方法制得的3’-SL的纯度有待进一步提升,因此,本申请基于该多酶催化制备3’-SL的转化液而开发了一种对转化液中3’-SL进一步分离纯化方法,以期进一步提升产物3’-SL的纯度。The existing method for preparing sialyllactose is, for example, the application number is CN201910787973.7, and the patent name is a method for preparing sialyllactose. The invention uses a single-bacteria multi-enzyme method combined with a one-step purification and immobilization method to immobilize multiple enzymes to achieve The one-pot method of CTP regeneration and multi-enzyme recycling during the preparation of sialyllactose has the advantages of high yield, low cost, and short cycle time. However, the purity of 3'-SL produced by this method needs to be further improved. Therefore, Based on the multi-enzyme catalyzed conversion solution for preparing 3'-SL, this application developed a method for further separation and purification of 3'-SL in the conversion solution, in order to further improve the purity of the product 3'-SL.

发明内容Contents of the invention

针对现有技术中存在的问题,本发明旨在提供一种高纯度3’-唾液酸乳糖的分离纯化方法,通过对多酶催化的转化液中3’-SL进一步分离纯化,由本发明所述方法分离纯化后的3’-SL的纯度不低于96%。In view of the problems existing in the prior art, the present invention aims to provide a method for separating and purifying high-purity 3'-sialyllactose, by further separating and purifying 3'-SL in the multi-enzyme catalyzed conversion solution, as described in the present invention. The purity of 3'-SL after separation and purification by the method is not less than 96%.

基于上述目的,本发明采用的技术方案如下:Based on the above objectives, the technical solutions adopted by the present invention are as follows:

一种高纯度3’-唾液酸乳糖的分离纯化方法,包括如下步骤:A method for separating and purifying high-purity 3’-sialyllactose, including the following steps:

S1:将转化液进行加热灭酶处理,经30~100nm滤膜过滤,收集滤液;S1: Heat the transformation solution to inactivate the enzyme, filter it through a 30-100nm filter membrane, and collect the filtrate;

S2:调节步骤S1收集滤液的pH至碱性,经3000Da~5000Da膜过滤,收集滤液;S2: Adjust the pH of the filtrate collected in step S1 to alkaline, filter it through a 3000Da~5000Da membrane, and collect the filtrate;

S3:调节步骤S2收集滤液的pH至中性,经800Da~1000Da膜过滤浓缩,收集膜上浓缩液;S3: Adjust the pH of the filtrate collected in step S2 to neutral, filter and concentrate through 800Da~1000Da membrane, and collect the concentrated liquid on the membrane;

S4:将经步骤S3所得膜上浓缩液再依次经阴阳离子交换树脂吸附、浓缩、干燥制得3’-SL。S4: The concentrated solution on the membrane obtained in step S3 is adsorbed, concentrated and dried by anion and cation exchange resins in sequence to prepare 3’-SL.

本发明通过步骤S1对转化液进行加热灭酶处理,促使转化液中的酶等蛋白质以及菌体和其它大颗粒杂质受热沉淀析出,经30~100nm滤膜过滤,有效去除转化液中的菌体、大颗粒杂质以及析出的酶等蛋白,当滤膜的孔径超出此范围,则会使得菌体去除不完全,产物纯度低。The present invention performs heating and enzyme-killing treatment on the transformation solution through step S1, so that proteins such as enzymes, bacteria and other large particle impurities in the transformation solution are heated to precipitate out, and are filtered through a 30-100nm filter membrane to effectively remove bacteria in the transformation solution. , large particle impurities and precipitated enzymes and other proteins. When the pore size of the filter membrane exceeds this range, the removal of bacteria will be incomplete and the product purity will be low.

在步骤S2中,将滤液的pH调节至碱性,使得滤液的pH达到转化液中剩余蛋白的等电点,进一步促使蛋白沉淀析出,并经3000Da~5000Da膜过滤,进一步去除转化液中的蛋白质。之所以选择3000Da~5000Da膜进行过滤除杂,是由于3’-SL的分子量小于3000Da,过滤时能够穿过膜进入滤液,而杂质则被截留于膜内。当膜分子量超出3000Da~5000Da范围,则会导致大分子杂质与目标物3’-SL一同透过有机膜而无法达到将目标物与杂质分离的目的。In step S2, the pH of the filtrate is adjusted to alkaline, so that the pH of the filtrate reaches the isoelectric point of the remaining protein in the transformation solution, further promoting protein precipitation, and filtering through a 3000Da to 5000Da membrane to further remove the protein in the transformation solution. . The reason why 3000Da to 5000Da membranes are selected for filtration and impurity removal is because the molecular weight of 3’-SL is less than 3000Da, and it can pass through the membrane and enter the filtrate during filtration, while impurities are trapped in the membrane. When the molecular weight of the membrane exceeds the range of 3000Da to 5000Da, it will cause macromolecular impurities to pass through the organic membrane together with the target 3’-SL, and the purpose of separating the target and impurities cannot be achieved.

随后在步骤S3中,将滤液的pH调节至中性并利用800Da~1000Da膜进行过滤浓缩,所得浓缩液经阴阳离子交换树脂吸附、浓缩、干燥制得3’-SL。同样,当有机膜的分子量超出800Da~1000Da范围,则导致乳糖、甘油、唾液酸等小分子杂质无法与目标物3’-SL分离,致使3’-SL的纯度难以进一步提升。Then in step S3, the pH of the filtrate is adjusted to neutral and filtered and concentrated using an 800Da to 1000Da membrane. The resulting concentrated liquid is adsorbed by anion and cation exchange resins, concentrated, and dried to prepare 3'-SL. Similarly, when the molecular weight of the organic membrane exceeds the range of 800Da to 1000Da, small molecule impurities such as lactose, glycerol, and sialic acid cannot be separated from the target 3’-SL, making it difficult to further improve the purity of 3’-SL.

在本发明S1~S3过膜除杂纯化过程中,过膜顺序是根据转化液中杂质的粒径大小进行,先过滤去除粒径大的肉眼可见的杂质,然后去除一些残留的蛋白,最后去除比目标物更小的乳糖、甘油、唾液酸以及部分,实际操作过程中尝试过更换过膜顺序或省略部分过膜工序,发现更换顺序后极易发生堵膜使过膜效率大幅降低,省略部分过膜工序后最终产品纯度无法达到现有水平。In the membrane impurity removal and purification process of S1 to S3 of the present invention, the sequence of membrane passing is based on the particle size of the impurities in the transformation solution. First, filter to remove visible impurities with large particle sizes, then remove some residual proteins, and finally remove For lactose, glycerol, sialic acid and some parts that are smaller than the target substance, during the actual operation, I tried to change the order of membrane passing or omit part of the membrane passing process. It was found that after changing the order, it is easy to cause membrane clogging, which greatly reduces the membrane passing efficiency. Some parts were omitted. After the membrane process, the purity of the final product cannot reach the current level.

此外,经试验发现,转化液中蛋白质的有效去除对于进一步提高产物3’-SL 的纯度具有重要作用,由于转化液中成分的复杂性,通常采用加热变性沉淀的方式去除蛋白,本申请进一步试验发现转化液中还含有热不敏感性蛋白,但该热不敏感性蛋白能够通过调节pH至其等电点而进一步去除,而该步骤则是现有唾液酸乳糖分离纯化过程中极易忽略的步骤,故本发明采用热处理和调节pH两种方式,对转化液中的蛋白质进行有效去除,显著提高了产物3’-SL的纯度。In addition, it was found through experiments that the effective removal of proteins in the transformation solution plays an important role in further improving the purity of the product 3'-SL. Due to the complexity of the components in the transformation solution, heating denaturation and precipitation are usually used to remove proteins. This application further tested It was found that the conversion solution also contained a heat-insensitive protein, but the heat-insensitive protein could be further removed by adjusting the pH to its isoelectric point. This step is easily ignored in the existing separation and purification process of sialyllactose. step, so the present invention adopts two methods: heat treatment and pH adjustment to effectively remove the protein in the transformation solution and significantly improve the purity of the product 3'-SL.

进一步地,步骤S2中调节步骤S1收集滤液的pH至10~12。Further, in step S2, the pH of the filtrate collected in step S1 is adjusted to 10-12.

由于转化液中的成分较为复杂,难以确知其中蛋白的种类进而确定其等电点,本发明通过将步骤S1收集滤液的pH分别调节至1、2、3、4、5、6、7、8、 9、10、11、12进行蛋白沉淀试验,结果发现当滤液的pH在8以下,无沉淀析出,pH=9时,有少量沉淀析出,当PH为10~12时,均有大量沉淀析出。因此,选择将步骤S1收集滤液的pH调节至10~12。Since the components in the transformation solution are relatively complex, it is difficult to determine the type of protein and then determine its isoelectric point. In the present invention, the pH of the filtrate collected in step S1 is adjusted to 1, 2, 3, 4, 5, 6, 7, respectively. 8, 9, 10, 11, and 12 conducted protein precipitation tests. The results showed that when the pH of the filtrate was below 8, no precipitation precipitated. When pH = 9, a small amount of precipitation precipitated. When the pH was 10 to 12, there was a large amount of precipitation. Precipitate. Therefore, it is selected to adjust the pH of the filtrate collected in step S1 to 10-12.

进一步地,步骤S2中调节步骤S1收集滤液的pH=10。Further, in step S2, the pH of the filtrate collected in step S1 is adjusted to 10.

由于前期试验已证实当将步骤S1收集滤液的pH调节至10时,已经有大量的沉淀析出,由于后期还需要利用酸将滤液中的碱进行中和,若前期将pH调整的过高,则后续酸碱中和形成的盐量过大,则会增加后续脱盐的压力,甚至造成目标产物纯度的降低,故控制步骤S1收集滤液的pH=10较为适宜。Preliminary experiments have confirmed that when the pH of the filtrate collected in step S1 is adjusted to 10, a large amount of precipitates have already precipitated. Since it is necessary to use acid to neutralize the alkali in the filtrate in the later stage, if the pH is adjusted too high in the early stage, then If the amount of salt formed by subsequent acid-base neutralization is too large, it will increase the pressure of subsequent desalination and even cause a decrease in the purity of the target product. Therefore, it is more appropriate to control the pH of the filtrate collected in step S1 = 10.

进一步地,步骤S3膜上浓缩液中3’-SL的浓度为10~30g/L。Further, the concentration of 3’-SL in the concentrated solution on the membrane in step S3 is 10-30g/L.

经试验发现,浓缩液中3’-SL的浓度对于阴阳离子交换树脂吸附纯化过程及终产物3’-SL的纯度有重要影响,当浓缩液中3’-SL的浓度高于30g/L时,不仅会造成树脂的损失,除盐效果差,导致大量盐分残留而影响产物的收率和纯度,使得产物的收率降低至85%,纯度不高于90%;当浓缩液中3’-SL的浓度低于 10g/L时,导致阴阳离子交换树脂的处理体系变大,处理效率极大降低;而当浓缩液中3’-SL的浓度为10~30g/L时,产物3’-SL的收率不低于91%,且3’-SL 的纯度不低于96%,因此,调整步骤S3膜上浓缩液中3’-SL的浓度为10~30g/L,同时能够获得较高的收率以及产物较高的纯度。It was found through experiments that the concentration of 3'-SL in the concentrated solution has an important impact on the anion and cation exchange resin adsorption and purification process and the purity of the final product 3'-SL. When the concentration of 3'-SL in the concentrated solution is higher than 30g/L , will not only cause the loss of resin, but also have poor desalination effect, resulting in a large amount of salt residue, which will affect the yield and purity of the product, reducing the yield of the product to 85% and the purity not higher than 90%; when 3'- in the concentrated solution When the concentration of SL is less than 10g/L, the treatment system of the anion and cation exchange resin becomes larger and the treatment efficiency is greatly reduced; when the concentration of 3'-SL in the concentrated solution is 10 to 30g/L, the product 3'- The yield of SL is not less than 91%, and the purity of 3'-SL is not less than 96%. Therefore, the concentration of 3'-SL in the concentrated solution on the membrane in step S3 is adjusted to 10-30g/L, and at the same time, a relatively high yield can be obtained. High yield and high purity of the product.

进一步地,步骤S1将转化液进行加热灭酶处理的方法如下:将转化液于 80~100℃加热8~15min。Further, the method of heating the transformation solution to inactivate the enzyme in step S1 is as follows: heating the transformation solution at 80-100°C for 8-15 minutes.

进一步地,经步骤S1~S4纯化干燥制得的3’-SL的纯度≥96%。Further, the purity of 3’-SL obtained by purification and drying in steps S1 to S4 is ≥96%.

与现有技术相比,本发明的有益效果如下:Compared with the prior art, the beneficial effects of the present invention are as follows:

本发明通过对转化液进行加热灭酶过滤、调节滤液pH至碱性后过滤,再将滤液的pH调节至中性、经浓缩、离子吸附、干燥处理后获得纯化的3’-SL,本发明采用加热灭酶和调节pH至碱性两种方式综合提升转化液中蛋白等大分子物质的去除率,同时控制浓缩液中3’-SL的浓度,对于阴阳离子吸附纯化进一步提高产物3’-SL的纯度具有重要作用,综合上述方法获得的产物3’-SL的纯度≥ 96%。The present invention obtains purified 3'-SL by heating and enzyme-killing filtration of the conversion solution, adjusting the pH of the filtrate to alkaline and then filtering, and then adjusting the pH of the filtrate to neutral, concentrating, ion adsorbing, and drying. The two methods of heating to inactivate enzymes and adjusting the pH to alkaline are used to comprehensively improve the removal rate of proteins and other macromolecules in the conversion solution. At the same time, the concentration of 3'-SL in the concentrated solution is controlled to further improve the product 3'- for adsorption and purification of anions and cations. The purity of SL plays an important role. The purity of the product 3'-SL obtained by combining the above methods is ≥ 96%.

附图说明Description of drawings

图1为本发明工艺流程示意图。Figure 1 is a schematic diagram of the process flow of the present invention.

具体实施方式Detailed ways

为更好地说明本发明的目的、技术方案和优点,下面将结合具体实施例对本发明作进一步说明。本领域技术人员应当理解,此处所描述的具体实施例仅用以解释本发明,并不用于限定本发明。In order to better illustrate the purpose, technical solutions and advantages of the present invention, the present invention will be further described below with reference to specific embodiments. Those skilled in the art should understand that the specific embodiments described here are only used to explain the present invention and are not intended to limit the present invention.

实施例中所用的试验方法如无特殊说明,均为常规方法;所用的材料、试剂等,如无特殊说明,均可从商业途径得到。本发明所用转化液源于由申请号为CN201910787973.7,专利名称为一种制备唾液酸乳糖的方法中所述方法制得的转化液。Unless otherwise specified, the test methods used in the examples are conventional methods; unless otherwise specified, the materials and reagents used can be obtained from commercial sources. The transformation liquid used in the present invention is derived from the transformation liquid prepared by the method described in the application number CN201910787973.7 and the patent name is a method for preparing sialyllactose.

实施例1Example 1

本实施例提供一种高纯度3’-唾液酸乳糖的分离纯化方法,如图1所示,包括如下步骤:This embodiment provides a method for separating and purifying high-purity 3’-sialyllactose, as shown in Figure 1, including the following steps:

S1:将转化液于90℃加热处理10min,灭活转化液中酶的活性,并促使其蛋白变性沉淀析出,同时促使转化液中的菌体、大颗粒杂质及非酶蛋白质变性沉淀析出,随后利用30nm陶瓷滤膜过滤去除上述沉淀物,当达到陶瓷膜的最小循环体积后,添加陶瓷膜最小循环体积2倍的水进一步循环膜过滤,进一步去除上述析出沉淀物,得到含有3’-SL的清液,该步骤对转化液中3’-SL的收率高达95%。S1: Heat the transformation solution at 90°C for 10 minutes to inactivate the activity of the enzyme in the transformation solution and promote the denaturation and precipitation of the protein. At the same time, the bacterial cells, large particle impurities and non-enzyme proteins in the transformation solution are denatured and precipitated, and then Use a 30nm ceramic filter membrane to filter to remove the above-mentioned precipitates. When the minimum circulation volume of the ceramic membrane is reached, add water twice the minimum circulation volume of the ceramic membrane to further circulate the membrane for filtration to further remove the above-mentioned precipitated precipitates to obtain 3'-SL. The yield of 3'-SL in the conversion solution in this step is as high as 95%.

S2:向由步骤S1收集的清液中加入碱,调节清液的pH=10,促使清液中的蛋白质如CMP激酶、多聚磷酸激酶、CMP-唾液酸合成酶及细胞破碎释放的其它杂蛋白等达到其等电点聚集沉淀析出,随后经3000Da的有机膜过滤,去除蛋白质沉淀物及大分子杂质,如六偏磷酸钠,在该步骤中,通过向过滤体系中加入初始过膜体积4~6倍的水进行循环膜过滤,收集滤液,有效去除清液中的六偏磷酸钠等大分子物质。S2: Add alkali to the clear liquid collected in step S1, adjust the pH of the clear liquid = 10, and promote proteins in the clear liquid such as CMP kinase, polyphosphate kinase, CMP-sialic acid synthase and other impurities released by cell disruption. Proteins, etc. reach their isoelectric point, aggregate and precipitate, and are then filtered through a 3000Da organic membrane to remove protein precipitates and macromolecular impurities, such as sodium hexametaphosphate. In this step, an initial membrane passage volume of 4 is added to the filtration system. ~6 times the water is used for circulating membrane filtration, and the filtrate is collected to effectively remove macromolecular substances such as sodium hexametaphosphate in the clear liquid.

在对步骤S1收集的清液进行pH调节过程中,由于清液中的成分较为复杂,难以确知其中蛋白的种类进而确定其等电点,本案发明人通过将步骤S1收集的清液的pH分别调节至1、2、3、4、5、6、7、8、9、10、11、12,结果发现清液的pH在8以下,无沉淀析出;pH=9时,有少量沉淀析出,当PH为10~12 时,均有大量沉淀析,故而选择将步骤S1收集的清液的pH调整至10~12,能够进一步去除大量蛋白杂质,为避免pH过高导致后续酸碱中和成盐的量过大,进一步导致后续脱盐的压力及脱盐效果不佳,致使目标产物纯度下降,故将步骤S1收集的清液的pH调整至10更为适宜。During the pH adjustment process of the clear liquid collected in step S1, since the components in the clear liquid are relatively complex, it is difficult to determine the type of protein and then determine its isoelectric point. The inventor of this case adjusted the pH of the clear liquid collected in step S1. Adjusted to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 respectively. It was found that the pH of the clear liquid was below 8 and no precipitation occurred; when pH = 9, a small amount of precipitation occurred. , when the pH is 10 to 12, there is a large amount of precipitation, so we choose to adjust the pH of the clear liquid collected in step S1 to 10 to 12, which can further remove a large amount of protein impurities. In order to avoid the subsequent acid-base neutralization caused by excessive pH Excessive amount of salt formation will further lead to poor subsequent desalination pressure and desalination effect, resulting in a decrease in the purity of the target product. Therefore, it is more appropriate to adjust the pH of the clear liquid collected in step S1 to 10.

S3:向步骤S2的滤液中加入酸调节滤液的pH至中性,随后经1000Da的有机膜进行过滤除杂、浓缩,收集膜上浓缩液,过滤除杂主要是指去除小分子物质如盐、七水氯化镁、唾液酸等物质。在该步骤中,通过向过滤体系中加入初始过膜体积5~10倍的水进行循环膜过滤,收集膜上浓缩液,并利用高效液相色谱对膜上浓缩液中3’-SL的浓度进行实时检测,直至膜上浓缩液中3’-SL的浓度为10~30g/L,停止循环膜过滤浓缩。S3: Add acid to the filtrate in step S2 to adjust the pH of the filtrate to neutral, and then filter and concentrate it through a 1000Da organic membrane to collect the concentrated liquid on the membrane. Filtration and impurity removal mainly refers to the removal of small molecular substances such as salt, Magnesium chloride heptahydrate, sialic acid and other substances. In this step, cyclic membrane filtration is performed by adding 5 to 10 times the initial membrane volume of water to the filtration system, collecting the concentrated liquid on the membrane, and using high performance liquid chromatography to measure the concentration of 3'-SL in the concentrated liquid on the membrane. Carry out real-time detection until the concentration of 3'-SL in the concentrated liquid on the membrane is 10-30g/L, and stop the circulating membrane filtration and concentration.

S4:将步骤S3所得浓缩液利用阴阳离子交换的方法深度除盐:首先利用阳离子树脂吸附纯化、再利用阴离子吸附纯化进一步去除浓缩液中的盐类物质,经过该阴阳离子交换除盐,能够将转化液中的导电率降低90%左右。随后将除盐后的液体经浓缩、干燥(冻干或喷雾干燥)制得3’-SL,经步骤S1~S4处理后分离得到的3’-SL的纯度不低于96%。S4: Deeply desalinate the concentrated liquid obtained in step S3 using anion and cation exchange methods: first use cation resin adsorption and purification, and then use anion adsorption and purification to further remove salt substances in the concentrated liquid. Through this anion and cation exchange desalination, the salt can be The conductivity in the conversion solution is reduced by about 90%. The desalted liquid is then concentrated and dried (lyophilized or spray dried) to prepare 3’-SL. The purity of the 3’-SL isolated after steps S1 to S4 is not less than 96%.

经试验发现,步骤S3所得浓缩液中3’-SL的浓度对于阴阳离子交换树脂吸附纯化过程及终产物3’-SL的纯度有重要影响,当浓缩液中3’-SL的浓度高于 30g/L时,不仅会造成树脂的损失,除盐效果差,导致大量盐分残留而影响产物的收率和纯度,使得产物的收率降低至85%,纯度不高于90%;当浓缩液中3’-SL 的浓度低于10g/L时,导致阴阳离子交换树脂的处理体系变大,处理效率极大降低;而当浓缩液中3’-SL的浓度为10~30g/L时,使得产物3’-SL的收率不低于 91%,且3’-SL的纯度不低于96%,因此,控制步骤S3膜上浓缩液中3’-SL的浓度为10~30g/L,同时能够获得较高的收率以及产物较高的纯度。It was found through experiments that the concentration of 3'-SL in the concentrated solution obtained in step S3 has an important influence on the anion and cation exchange resin adsorption and purification process and the purity of the final product 3'-SL. When the concentration of 3'-SL in the concentrated solution is higher than 30g /L, not only will it cause the loss of resin, but the desalination effect is poor, resulting in a large amount of salt residue, which will affect the yield and purity of the product, reducing the yield of the product to 85% and the purity not higher than 90%; when the concentrated solution When the concentration of 3'-SL is lower than 10g/L, the treatment system of the anion and cation exchange resin becomes larger and the treatment efficiency is greatly reduced; when the concentration of 3'-SL in the concentrated solution is 10-30g/L, the treatment system of the anion and cation exchange resin becomes larger and the treatment efficiency is greatly reduced. The yield of the product 3'-SL is not less than 91%, and the purity of 3'-SL is not less than 96%. Therefore, the concentration of 3'-SL in the concentrated solution on the membrane in step S3 is controlled to be 10 to 30g/L. At the same time, higher yield and higher purity of the product can be obtained.

实施例2Example 2

本实施例提供一种高纯度3’-唾液酸乳糖的分离纯化方法,包括如下步骤:This embodiment provides a method for separating and purifying high-purity 3’-sialyllactose, which includes the following steps:

S1:将3’-SL转化液于90℃加热10min,灭活转化体系中的酶的活性,并使热敏性蛋白质变性沉淀析出;将加热后的转化液经30nm陶瓷膜过滤,去除菌体、大颗粒杂质以及析出的杂蛋白,得到含3’-SL的清液,加水透析直至收率不低于95%。S1: Heat the 3'-SL transformation solution at 90°C for 10 minutes to inactivate the enzyme activity in the transformation system and denature and precipitate heat-sensitive proteins; filter the heated transformation solution through a 30nm ceramic membrane to remove bacteria and macrophages. Particulate impurities and precipitated impurity proteins are obtained to obtain a clear liquid containing 3'-SL, which is dialyzed with water until the yield is not less than 95%.

S2:将3’-SL清液加碱调节其pH至10,促使未热变性蛋白在等电点沉降,然后经3000D有机膜过滤,进一步去除沉降蛋白和一些可溶性大分子杂质(如转化体系中的六偏磷酸钠等),加水透析直至收率不低于90%。S2: Add alkali to the 3'-SL clear solution to adjust its pH to 10 to promote the precipitation of the unheated denatured protein at the isoelectric point, and then filter it through a 3000D organic membrane to further remove the precipitated protein and some soluble macromolecular impurities (such as in the transformation system sodium hexametaphosphate, etc.), add water and dialyze until the yield is not less than 90%.

S3:收集过3000D膜的清液加酸调节其pH至7,然后过1000D有机膜,去除其中的一价盐和小分子杂质,加水透析直至浓液电导率均不再变化,收集膜上清液,膜上清液中3’-SL的浓度在10~30g/L范围内。S3: Collect the clear liquid that has passed through the 3000D membrane and add acid to adjust its pH to 7, then pass through the 1000D organic membrane to remove monovalent salts and small molecule impurities, add water and dialyze until the conductivity of the concentrate no longer changes, collect the membrane supernatant liquid, the concentration of 3'-SL in the membrane supernatant is in the range of 10 to 30g/L.

S4:然后利用离子交换树脂对膜上清液进一步脱盐;向脱盐后清液加入0.1%活性炭脱色,然后浓缩喷雾干燥得3’-SL,其纯度为98%。S4: Then use ion exchange resin to further desalt the membrane supernatant; add 0.1% activated carbon to the desalted supernatant to decolorize, and then concentrate and spray dry to obtain 3’-SL, with a purity of 98%.

对比例1Comparative example 1

参照实施例2所述方法分离纯化3’-SL,本对比例与实施例2的区别仅在于步骤S2和步骤S3中未经过“将3’-SL清液加碱调节其pH至10”和“收集过 3000D膜的清液加酸调节其pH至7”处理过程,其余步骤同实施例2。3'-SL was separated and purified with reference to the method described in Example 2. The only difference between this comparative example and Example 2 is that in steps S2 and S3, "adding alkali to the 3'-SL clear liquid to adjust its pH to 10" and "Collect the clear liquid that has passed through the 3000D membrane and add acid to adjust its pH to 7", and the remaining steps are the same as in Example 2.

由本对比例所述方法分离纯化得到的3’-SL的纯度为95%。The purity of 3'-SL separated and purified by the method described in this comparative example is 95%.

对比例2Comparative example 2

参照实施例2所述方法,本对比例与实施例2的区别仅在于步骤S1未进行“将3’-SL转化液于90℃加热10min”处理过程,其余步骤同实施例2。Referring to the method described in Example 2, the only difference between this comparative example and Example 2 is that step S1 does not carry out the process of "heating the 3'-SL conversion solution at 90°C for 10 minutes", and the remaining steps are the same as in Example 2.

由本对比例所述方法分离纯化得到的3’-SL的纯度为80%。The purity of 3'-SL separated and purified by the method described in this comparative example is 80%.

对比例3Comparative example 3

参照实施例2所述方法,本对比例与实施例2的区别仅在于步骤S1未进行“将3’-SL转化液于90℃加热10min”处理过程,同时步骤S2和步骤S3中未经过“将3’-SL清液加碱调节其pH至10”和“收集过3000D膜的清液加酸调节其pH至7”处理过程,其余步骤同实施例2。Referring to the method described in Example 2, the only difference between this comparative example and Example 2 is that the process of "heating the 3'-SL transformation solution at 90°C for 10 minutes" was not performed in step S1, and the " Add alkali to the 3'-SL clear liquid to adjust its pH to 10" and "Collect the clear liquid that has passed the 3000D membrane and add acid to adjust its pH to 7". The remaining steps are the same as in Example 2.

由本对比例所述方法分离纯化得到的3’-SL的纯度为60%。The purity of 3'-SL separated and purified by the method described in this comparative example is 60%.

由实施例2、对比例1、对比例2和对比例3的结果对比可知,尽管转化液中成分复杂,本发明采用对转化液进行热处理和调节PH的方式,综合提升了最终分离得到的3’-SL的纯度。From the comparison of the results of Example 2, Comparative Example 1, Comparative Example 2 and Comparative Example 3, it can be seen that although the components in the conversion liquid are complex, the present invention adopts the method of heat treatment and pH adjustment of the conversion liquid to comprehensively improve the final separation of 3 '-SL purity.

最后所应当说明的是,以上实施例仅用以说明本发明的技术方案而非对本发明保护范围的限制,尽管参照较佳实施例对本发明作了详细说明,本领域的普通技术人员应当理解,可以对本发明的技术方案进行修改或者等同替换,而不脱离本发明技术方案的实质和范围。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and do not limit the protection scope of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those of ordinary skill in the art should understand that The technical solution of the present invention may be modified or equivalently substituted without departing from the essence and scope of the technical solution of the present invention.

Claims (3)

1.一种高纯度3’-唾液酸乳糖的分离纯化方法,其特征在于,包括如下步骤:1. A method for separating and purifying high-purity 3'-sialyllactose, which is characterized in that it includes the following steps: S1:将转化液进行加热灭酶处理,经30~100nm滤膜过滤,收集滤液;所述步骤S1将转化液进行加热灭酶处理的方法如下:将转化液于80~100℃加热8~15min;S1: Heat the transformation solution to inactivate the enzyme, filter it through a 30-100nm filter membrane, and collect the filtrate; the method for heating the transformation solution to inactivate the enzyme in step S1 is as follows: Heat the transformation solution at 80-100°C for 8-15 minutes ; S2:调节步骤S1收集滤液的pH至碱性,经3000Da~5000Da膜过滤,收集滤液;所述步骤S2中调节步骤S1收集滤液的pH至10~12;S2: Adjust the pH of the filtrate collected in step S1 to alkaline, filter it through a 3000Da-5000Da membrane, and collect the filtrate; in step S2, adjust the pH of the filtrate collected in step S1 to 10-12; S3:调节步骤S2收集滤液的pH至中性,经800Da~1000Da膜过滤浓缩,收集膜上浓缩液;所述步骤S3膜上浓缩液中3’-SL的浓度为10~30g/L;S3: Adjust the pH of the filtrate collected in step S2 to neutral, filter and concentrate through an 800Da-1000Da membrane, and collect the concentrated liquid on the membrane; the concentration of 3’-SL in the concentrated liquid on the membrane in step S3 is 10-30g/L; S4:将经步骤S3所得膜上浓缩液再依次经阴阳离子交换树脂吸附、浓缩、干燥制得3’-SL。S4: The concentrated solution on the membrane obtained in step S3 is adsorbed, concentrated and dried by anion and cation exchange resins in sequence to prepare 3’-SL. 2.根据权利要求1所述方法,其特征在于,所述步骤S2中调节步骤S1收集滤液的pH=10。2. The method according to claim 1, characterized in that in step S2, the pH of the filtrate collected in step S1 is adjusted to 10. 3.根据权利要求1或2所述方法,其特征在于,经步骤S1~S4制得的3’-SL的纯度≥96%。3. The method according to claim 1 or 2, characterized in that the purity of 3’-SL prepared through steps S1 to S4 is ≥96%.
CN202111179169.4A 2021-10-09 2021-10-09 Separation and purification method of high-purity 3' -sialyllactose Active CN114014896B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111179169.4A CN114014896B (en) 2021-10-09 2021-10-09 Separation and purification method of high-purity 3' -sialyllactose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111179169.4A CN114014896B (en) 2021-10-09 2021-10-09 Separation and purification method of high-purity 3' -sialyllactose

Publications (2)

Publication Number Publication Date
CN114014896A CN114014896A (en) 2022-02-08
CN114014896B true CN114014896B (en) 2023-12-05

Family

ID=80055761

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111179169.4A Active CN114014896B (en) 2021-10-09 2021-10-09 Separation and purification method of high-purity 3' -sialyllactose

Country Status (1)

Country Link
CN (1) CN114014896B (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003093091A (en) * 2001-07-19 2003-04-02 Yamasa Shoyu Co Ltd Method for producing cmp-n-acetylneuraminic acid
JP2005008584A (en) * 2003-06-20 2005-01-13 Yakult Honsha Co Ltd Method for producing oligosaccharide containing sialic acid
CN102154163A (en) * 2010-12-31 2011-08-17 朱莉 Preparation method of 3'-sialic acid lactose
AU2017302181A1 (en) * 2016-07-28 2019-02-21 Fonterra Co-Operative Group Limited Dairy product and process
CN110396532A (en) * 2019-08-23 2019-11-01 中国科学院合肥物质科学研究院 A method for preparing sialyllactose
WO2021124234A1 (en) * 2019-12-19 2021-06-24 Glycom A/S Separation of sialylated oligosaccharides from fermentation broth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2001377C2 (en) * 2008-03-14 2009-09-15 Friesland Brands Bv Process for isolating sialic acid-containing oligosaccharides, as well as the compositions containing sialic acid-containing oligosaccharides.
ES2991621T3 (en) * 2016-03-07 2024-12-04 Glycom As Separation of oligosaccharides from fermentation broth
BR112020011242A2 (en) * 2017-12-08 2020-11-17 Jennewein Biotechnologie Gmbh spray dried mixture of human milk oligosaccharides
EP3801037B1 (en) * 2018-06-01 2022-10-19 Chr. Hansen HMO GmbH A simple method for the purification of a sialyllactose

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003093091A (en) * 2001-07-19 2003-04-02 Yamasa Shoyu Co Ltd Method for producing cmp-n-acetylneuraminic acid
JP2005008584A (en) * 2003-06-20 2005-01-13 Yakult Honsha Co Ltd Method for producing oligosaccharide containing sialic acid
CN102154163A (en) * 2010-12-31 2011-08-17 朱莉 Preparation method of 3'-sialic acid lactose
AU2017302181A1 (en) * 2016-07-28 2019-02-21 Fonterra Co-Operative Group Limited Dairy product and process
CN110396532A (en) * 2019-08-23 2019-11-01 中国科学院合肥物质科学研究院 A method for preparing sialyllactose
WO2021124234A1 (en) * 2019-12-19 2021-06-24 Glycom A/S Separation of sialylated oligosaccharides from fermentation broth

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
牛初乳中唾液酸乳糖与乳糖的色谱分离;李明等;《过程工程学报》;第17卷(第3期);第506-511页 *

Also Published As

Publication number Publication date
CN114014896A (en) 2022-02-08

Similar Documents

Publication Publication Date Title
AU2018343981B2 (en) Process for the purification of a neutral human milk oligosaccharide (HMO) from microbial fermentation
CN102250240B (en) Method for purifying human immunoglobulin from separated component I+III of blood plasma
CN103275246B (en) A kind of nadroparin calcium production method
US11091381B1 (en) Method for extracting antibacterial peptides and albumin from pea whey wastewater
CN104530143B (en) Method for preparing soybean whey oligosaccharide through coupling of heating, flocculating, air floating and ultra-filtering
CN111647027A (en) Method for separating and purifying N-acetylglucosamine
CN103965377A (en) Method for preparing synanthrin from jerusalem artichoke
CN102875669B (en) Method for separating and extracting ovotransferrin
JPH10513437A (en) How to process cheese processing waste
CN112111546B (en) A kind of industrialized preparation method of phosphatin phosphopeptide and yolk polypeptide
CN114032261A (en) Method for obtaining high-purity fucosyllactose by degrading lactose in fermentation liquor
CN104072636B (en) The preparation technology of heparin sodium
CN116075517A (en) Improved demineralization of fermentation broths and purification of fine chemicals such as oligosaccharides
CN103992363B (en) Utilize the method that beer waste yeast prepares trehalose and yeast extract
CN107043431B (en) Purification method of bacterial capsular polysaccharide
CN114014896B (en) Separation and purification method of high-purity 3' -sialyllactose
WO2022090450A1 (en) Process for the purification of an acidic human milk oligosaccharide from fermentation broth
CN112175101A (en) Method for preparing fucoidin by using algin processing waste liquid
CN106799167A (en) The method that a kind of double films of ultrafiltration/nanofiltration efficiently purify pumpkin oligosaccharide
CN106317255A (en) A kind of method adopting ion-exchange resin deacidification to prepare neutral chitosan oligosaccharide
CN101400807A (en) Process for producing sugar
CN106434781B (en) A kind of L-Glutamine fermentation method process for cleanly preparing
CN102219846A (en) Method for separating CGMP (casein glycomacropeptide) having high content of sialic acid by using ion exchange resin
JP2635210B2 (en) Manufacturing method of soybean oligosaccharide
CN119528999A (en) A method for improving the purity of 6-SL

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant